SAiGENCI Group Leader - Tumour Inflammation and Immunotherapy

Job no:512130
Work type:Fixed term - Full-time
Campus:Adelaide
Categories:Faculty of Health & Medical Sciences, Level C, Level D

(Level C) $125, 537 to $144,368 per annum or (Level D) $150,639 to $165,698 per annum plus an employer contribution of up to 17% superannuation.

Fixed term, full-time position available for five years.

We invite applications to join the Tumour Inflammation and Immunotherapy Program at SAiGENCI as a Research Group Leader.

The South Australian immunoGENomics Cancer Institute (SAiGENCI) operates as an independent institute within the University of Adelaide and in alliance with the Central Adelaide Local Health Network (CALHN). SAiGENCI supports and promotes collaborations with other cancer research centres in Australia. SAiGENCI aims to develop the highest quality scientific program to achieve its chief goal of making discoveries to decrease the burden of cancer, by attracting and retaining brilliant biomedical and clinical researchers. The Institute will also have a global reach by collaborating with like-minded centres of excellence across the globe.

SAiGENCI will provide a focal point for cancer research in the South Australian Biomedical Precinct and through this, enable South Australian participation in the developing Australian network of cancer institutes, and national and international clinical trials partnerships. In so doing, SAiGENCI will help develop world-class and life-changing treatments and improve the outcomes of patients with cancer.

The overarching vision for SAiGENCI is to have a fundamentally positive impact on the conduct of cancer research, so that fewer patients develop cancer, and the lives of those with cancer is improved.

Tumour Inflammation and Immunotherapy

The Tumour Inflammation and Immunotherapy program, led by Professor Brendan Jenkins, will aim to manipulate both innate and adaptive arms of the immune system, including augmentation of tumour antigenicity and modulation of the inflammatory response, as key strategies to suppress tumourigenesis. The program is seeking particular interest from leading researchers with expertise in NK and/or T cell-based immunotherapy or adaptive immunity. The cancer type to be targeted is not defined, with a tissue agnostic approach that has potential to apply to multiple cancers.

Enjoy an outstanding career environment

The University of Adelaide is a uniquely rewarding workplace. The size, breadth and quality of our education and research programs - including significant industry, government and community collaborations - offers you a vast scope and opportunity for a long, fulfilling career.

It also enables us to attract high-calibre people in all facets of our operations, ensuring you will be surrounded by talented colleagues, many world-leading. Our work's cutting-edge nature - not just in your own area, but across virtually the full spectrum of human endeavour - provides a constant source of inspiration.

Our culture is one that welcomes all and embraces diversity consistent with our Staff Values and Behaviour Framework and our Values of integrity, respect, collegiality, excellence and discovery. We firmly believe that our people are our most valuable asset, so we work to grow and diversify the skills, knowledge and capability of all our staff.

We embrace flexibility as a key principle to allow our people to manage the changing demands of work, personal and family life.

In addition, we offer a wide range of attractive staff benefits. These include: salary packaging; flexible work arrangements; high-quality professional development programs and activities; and an on-campus health clinic, gym and other fitness facilities.

Learn more at: adelaide.edu.au/jobs

Your faculty's broader role

The Faculty of Health and Medical Sciences contains one of Australia's largest concentrations of leading health researchers, teachers and clinical titleholders. It's comprised of eight schools and a number of specialist disciplines, institutes and centres, variously focused on world-class research, and training the next generation of: medical doctors; surgeons; dentists; nurses; psychiatrists; psychologists; and other health professionals.

Learn more at: health.adelaide.edu.au

If you have the talent, we'll give you the opportunity. Together, let's make history.

Click on the ‘Apply Now’ button to be taken through to the online application form. Please ensure you submit a cover letter, resume, and upload a document that includes your responses to all of the selection criteria for the position as contained in the position description or selection criteria document.

Applications close 11:55pm, 3 March 2024.

For further information

For a confidential discussion regarding this position, contact:

Professor Brendan Jenkins
Program Lead, Tumor Inflammation and Immunotherapy
SAiGENCI
E: [email protected]

You'll find a full position description and/or selection criteria below: (If no links appear, try viewing on another device)

The University of Adelaide is an Equal Employment Opportunity employer committed to providing a working environment that embraces and values diversity and inclusion. Female applicants, people with a disability and/or and Aboriginal and Torres Strait Islander people who meet the requirements of this position are strongly encouraged to apply. If you have any support or access requirements, we encourage you to advise us at time of application.

Download the Position Description Apply now